![]() ![]() “Agena brings an innovative approach to the challenges of clinical genomics. The COVID-19 revenues are expected to tail off significantly after that time. ![]() Additionally, Agena is also expected to deliver an additional $3 million to $5 million of COVID-19 related revenues during the first year of ownership at approximately the same gross profit percentages stated above. Additionally, excluding the impact of COVID-19 related revenues, purchase accounting and integration expenses, we expect adjusted operating income 1 as a percentage of revenues to approach 20% for the same first 12 months of ownership. Excluding the impact of COVID-19 related revenues, Agena is expected to add between $63 million to $67 million of revenues during the first 12 months of ownership (of which approximately 65% is expected to be recurring in nature), deliver high single digit organic revenues growth over the next several years and excluding the impact of purchase accounting, generate gross profit percentages in the mid to high 60’s. The transaction is expected to be completed in Mesa’s third fiscal quarter ending December 31, 2021, and is subject to customary conditions, including receipt of applicable regulatory approvals.Īgena is headquartered in San Diego, California and is a leading molecular diagnostics tools company that develops, manufactures, and supplies highly sensitive, low-cost, high-throughput, genetic analysis solutions to clinical labs and development partners globally. Mesa expects to finance the all-cash transaction with a combination of cash on hand and proceeds from our credit facility. (“Agena”) for a cash purchase price of $300 million, subject to customary purchase price adjustments. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. 14, 2021 (GLOBE NEWSWIRE) - Mesa Laboratories, Inc. David Toups, MD, for the STQN Citizenship Award in recognition for his coordination of COVID testing and treatment.LAKEWOOD, Colo., Sept.Angela Buonagura, MD, for the STQN Citizenship Award in recognition of her Community Outreach efforts along with patient navigation after screenings with the Be Well Program.Gary Agena, MD, for the STQN Citizenship Award in recognition of his participation in community education programs specific to Women’s Health and Breast Health awareness.Andy Stone, MD, for the STQN Citizenship Award in recognition of his efforts in leading the low dose CT screening initiative at STHS.Brianna McDaniel, MD, for the STQN Citizenship Award in recognition of her Community Outreach efforts specific to early detection and prevention of cancer.Joey LaMartina, MD: Zero readmissions for CJR and highest overall NPRA.Georges Antoun, MD: Lowest readmission rate for BPCI-A Cardiac episodes and highest NPRA per episode.Melissa Inman, MD: Lowest readmission rate for BPCI-A and highest NPRA per episode.Mohammad Almubaslat, MD: top performing specialist.Rob Faucheux, MD: top performing pediatric provider.Ralph Millet, MD: top performing primary care provider.BMI assessment and nutrition counseling.Well child visits in 3,4,5,6 years of life.Jennifer Miles, MD: MCIP Pediatrics, highest MCIP metrics in pediatric care.Libeau Berthelot, MD: MCIP Diabetes Management, highest MCIP diabetic overall metrics.Gabrielle Givens, MD: MCIP Hypertension Management, highest MCIP hypertension control rate (100%).Jill Gibson, MD: MCIP Maternal Care, lowest c-section rate.Top 2021 Medicaid Care Improvement Program (MCIP) Performers Ralph Millet, MD: OACN physician with the highest HCC recapture rate.Nathalie Mascherpa-Kerkow, MD: ACO physician with highest annual wellness visit completion.Charles Baier, MD: Highest performer in OACN on overall HEDIS metrics.Jennifer Miles, MD: Highest performer in Healthy Planet (payor agnostic) on overall HEDIS metrics in pediatrics.Glen Kesler, MD: Highest performer in Healthy Planet (payor agnostic) on overall HEDIS metrics in primary care.Robert Faucheux, MD: highest performer in pediatric well visits.Charles Baier, MD: highest performer in colorectal screening, diabetes nephropathy screening, breast cancer screening and cervical cancer screening.Tammany Health System singled out more than two dozen local care providers for healthcare excellence in 2021. Tammany Quality Network recently held its annual membership and awards event, at which the group of some 300 Northshore community physicians aligned with St. ![]()
0 Comments
Leave a Reply. |